Written by Pharmaceutical sciences are the field of drugs for different kinds of diseases. In the year 2010, there were a large number of discoveries and important advancements made in this field. Much of these researches are conducted with the assistance of testing and analytical centers which also carry out statistical analyses. One such research work was surrounding the apparent linkage between some cancer drugs and heart failures. Through path-breaking research work, scientists have found out that drugs and therapies like Sutent, Herceptin and Gleevec can effectively cause remission of cancer, but at the same time have caused deaths of patients from heart failure. Chemotherapy is another field that has been developed in the last couple of years and in 2010 itself, it was found out that if a patient is suffering from heart problems a few years into their chemotherapy programs, then the co-relation between the heart problems and the chemical therapy has to be found out.
In April 2010, in a landmark judgment, Provenge was accepted as a treatment for prostate cancer. This in turn gave rise to a series of research work surrounding immunotherapies for curing cancer. Provenge is in fact a vaccine that has been proven to have brought about significant improvements in cancer patients. Micromet is another organization that has been trying to produce antibodies similar to those in Provenge, called T-cells. The main objective of the T-cells is to somehow associate with the tumor cells to make the body immune to any future attacks from outside.
A certain kind of therapy, called Kinoid therapy, was found to be an extremely effective immunotherapy program in the year 2010. It was found to be more effective in fact than the existing programs like Humira, Enbrel and Remicade, which can cause infections and allergies. Organizations are responsible in a big way to provide assistance to these kinds of researches. A CRO in particular is an outsourcing and research partner for many pharmaceutical drugs and medical devices.
